News / American Regent
Melville, NY – February 3, 2022: American Regent announces the introduction and availability of FDA-approved Vasopressin Injection, USP. Vasopressin is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.
For patients as young as one year of age who have intolerance to, or have had an unsatisfactory response to, oral iron, Injectafer may now be administered for IDA treatment1
Basking Ridge, N.J. and Shirley, N.Y. (December 15, 2021) – Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved Injectafer for pediatric patients (who are 1 year of age or older) with iron deficiency anemia (IDA) who are intolerant to oral iron or who have had an unsatisfactory response to oral iron.
Melville, NY – September 2, 2021: American Regent, Inc. introduces FDA-approved Multrys™ (trace elements injection 4*, USP). Multrys™ is indicated in neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Melville, NY – July 1, 2020: – American Regent announces the introduction and availability of HydrALAZINE Hydrochloride Injection, USP—“AP” Rated and therapeutically equivalent to Apresoline® 1,2.
Melville, NY – July 1, 2020: – American Regent announces the introduction and availability of HydrALAZINE Hydrochloride Injection, USP—“AP” Rated and therapeutically equivalent to Apresoline® 1,2.
Basking Ridge, N.J. and Shirley, N.Y. (May 6, 2021): Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron, have had unsatisfactory response to oral iron, or have non-dialysis dependent chronic kidney disease (CKD).1
Shirley, NY – April 1, 2021: Paul Diolosa assumed the role of President and CEO of American Regent, Inc., a Daiichi Sankyo Group company, effective today.
Melville, NY – September 30, 2020: American Regent, Inc. announces the introduction of Tralement® (trace elements injection 4*, USP), the first and only FDA-approved multi-trace element injection.
Melville, NY – September 30, 2020: American Regent, Inc. announces the introduction of Tralement® (trace elements injection 4*, USP), the first and only FDA-approved multi-trace element injection.
Shirley, NY – May 7, 2020: American Regent announced the introduction of the only FDA approved USP standard Nicardipine Hydrochloride Injection.
Shirley, NY – American Regent announces the introduction and availability of Estradiol Valerate Injection, USP
Shirley, NY – American Regent, Inc. announced the introduction of FDA approved Zinc Sulfate Injection, USP.
Shirley, NY – American Regent, Inc. announced the introduction of FDA approved Zinc Sulfate Injection, USP.
Shirley, NY - American Regent today announced the introduction of Selenious Acid Injection, USP.
Shirley, NY - American Regent today announced the re-introduction of Aminocaproic Acid Injection, USP.
Shirley, NY - American Regent, Inc. today announced the re-introduction of Droperidol Injection, USP.
Luitpold Pharmaceuticals, Inc., a manufacturer and distributor of pharmaceuticals that addresses diverse medical and veterinary needs, announced it changed its legal name to American Regent, Inc. effective January 2, 2019.
The program offers fellowships in both Medical Affairs & Pharmaceutical Marketing and in Clinical Research & Development.
Shirley, NY — American Regent today announced the launch of Methocarbamol Injection, USP. Methocarbamol Injection, USP is available for immediate shipment. Customers can order Methocarbamol Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.
Shirley, NY — American Regent today announced the launch of 10% Calcium Chloride Injection, USP. 10% Calcium Chloride Injection, USP is available for immediate shipment. Customers can order 10% Calcium Chloride Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.
Shirley, NY — American Regent today announced the introduction of Neostigmine Methylsulfate Injection, USP. Product is available for immediate shipment and customers can order through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.
Shirley, NY — American Regent today announced the launch of Hydroxyprogesterone Caproate Injection, USP, the only preservative free generic alternative to Makena®.
Shirley, NY — American Regent today announced the launch and availability of Fomepizole Injection, AP rated and therapeutically equivalent to Antizol®.